Trial Profile
Effects of Nebivolol on Subclinical left ventricular dysfunction. A comparative study against Metoprolol.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary) ; Metoprolol
- Indications Hypertension; Left ventricular dysfunction
- Focus Pharmacodynamics
- Acronyms ENESYS
- Sponsors Menarini
- 22 Jul 2009 Actual patient number (60) added as reported by ClinicalTrials.gov.
- 22 Jul 2009 Actual end date (1 Jul 2009) added as reported by ClinicalTrials.gov.
- 22 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.